Department of Neurology

Department of Neurology
faculty photo

Clyde E. Markowitz, M.D.

Associate Professor of Neurology at the Hospital of the University of Pennsylvania
Department: Neurology

Contact information
Hospital of the University of Pennsylvania
3 West Gates Building
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-4521
Fax: 215-349-5579
Education:
B.S. (Business Administration)
State University of New York at Buffalo, 1982.
(Post-baccalaureate pre-med program)
Columbia University, 1986.
M.D. (Medicine)
Columbia Univ. College of Physicians & Surgeons, 1990.
Post-Graduate Training
Internal Medicine, Columbia-Presbyterian Medical Center New York, N.Y., 1990-1991.
Resident in Neurology, Neurological Institute-Columbia-Presbyterian Medical Center New York, N.Y. , 1991-1994.
Neuroimmunology/MS-Research/Clinical Postdoc. Fellowship, Neurological Institute- Columbia-Presbyterian Medical Center New York, N.Y., 1994-1998.
Certifications
National Board of Medical Examiners, 1991.
American Board of Psychiatry and Neurology, 1995.
American Board of Psychiatry and Neurology- Recertification, 2005.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Lublin F, Coyle P, Markowitz C: Interactive Case Studies in Multiple Sclerosis. Web, and CD; CME program. Postgraduate Institute for Medicine (PIM), July 2007.

Galetta S, Fox R, Markowitz C: Changing Therapy in Relapsing MS. Webcast-CME. Healthology.com, July 2007.

Markowitz, C: Commentary on "Prevalence of bladder, bowel and sexual problems among multiple sclerosis (MS) patients two to five years after diagnosis" MS Monitor and Commentary April 2007.

Wolinsky JS. Narayana PA. O'Connor P. Coyle PK. Ford C. Johnson K. Miller A. Pardo L. Kadosh S. Ladkani D. PROMiSe Trial Study Group. : Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Annals of Neurology 61(1): 14-24, Jan. 2007.

Markowitz, C: Interferon-beta: Mechanism of Action and Dosing Issues Neurology 68(Supp 4), 2007.

Bar-Or, A., Calabrese, P., Markowitz, C., Shafer, S., Kasper, L., Gazda, S., Fox, R., Sarkar, N., Panzara, P., Smith,C., on behalf of the U3264g Trial Group. : A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Activity of Rituximab in Adults with Relapsing-Remitting Multiple Sclerosis. Presented at the American Academy of Neurology Annual Meeting, Boston, Massachusetts 2007.

Glisson C., Frohman E., Balcer L., Jacobs D., Markowitz C., Galetta S.: Clinical characteristics associated with neuromyelitis optica (NMO) antibody seropositivity. Presented at the American Academy of Neurology Annual Meeting, Boston, Massachusetts. 2007.

Wu G.F., Schwartz E.D., Lei T., Souza A., Mishra S., Jacobs D.A., Markowitz C.E., Galetta S.L., Nano-Schiavi M.L., Desiderio L.M., Cutter G.R., Calabresi P.A., Udupa J.K., Balcer L.J: Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology 69(23), Dec. 2007.

Baime, MJ, Ladden, LJ, Levan, AJ, Hoffman, M, Markowitz, CE : Mindfulness-Based Stress Management for MS Patients and Caregivers. Presented at The ACTRIMS meeting in association with the 21st annual meeting of the Consortium of Multiple Sclerosis Centers, Washington D.C. 2007.

Nesler, L., Markowitz, C. Fox, E. Goodman, A. Green, B. Murray, R: The impact of regularly scheduled neutralizing antibody testing on treatment patterns versus usual care in MS patients taking high-dose interferon. Presented at the 21st annual meeting of the Consortium of Multiple Sclerosis Centers, Washington D.C 2007.

back to top
Last updated: 11/02/2009
The Trustees of the University of Pennsylvania